Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wolfe Research Upgrades Cushman & Wakefield to Outperform, Announces $12 Price Target

Author: Benzinga Newsdesk | December 08, 2023 05:30am
Wolfe Research analyst Andrew Rosivach upgrades Cushman & Wakefield (NYSE:CWK) from Peer Perform to Outperform and announces $12 price target.

Posted In: CWK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist